Miss Dikshyanta Rana

  • Research Assistant (Health Economics & Health Technology Assessment)

telephone: +44(0)141 330 6613
email: Dikshyanta.Rana@glasgow.ac.uk

1 Lilybank Gardens, Glasgow, G12 8RZ

ORCID iDhttps://orcid.org/0000-0001-9133-3094

Biography

Dikshyanta joined HEHTA in 2018. She has experience in performing economic evaluations alongside clinical trials, decision-analytic modelling, analysing linked health data and evidence synthesis. To date, her projects have focused on diverse areas such as cardiovascular diseases, oncology, women’s health and learning disabilities.

Dikshyanta has an MSc in Health Economics from the University of York. Her MSc placement was at the Mental Health and Addiction Research Group (MHARG), University of York. She obtained her undergraduate degree in BA (Hons) Economics, with Minor subjects Psychology and Sociology from Christ University, India in 2016.

 

Publications

List by: Type | Date

Jump to: 2021 | 2020
Number of items: 9.

2021

Rana, D. , Westrop, S., Germeni, E. , Mcgarty, A. , Ells, L., Lally, P., McEwan, M., Melville, C. , Harris, L. and Wu, O. (2021) Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: Protocol for a mixed-methods systematic review. Systematic Reviews, (Accepted for Publication)

Rana, D. et al. (2021) Uterine artery embolization or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial. BJOG: An International Journal of Obstetrics and Gynaecology, (doi: 10.1111/1471-0528.16781) (Early Online Publication)

Stock, S. J. et al. (2021) Cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study: a protocol. BMJ Open, 11(5), e050452. (doi: 10.1136/bmjopen-2021-050452) (PMID:33947741) (PMCID:33947741)

Quinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)

Bouttell, J. et al. (2021) Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Rana, D. et al. (2021) Healthcare costs for metastatic castration-resistant prostate cancer patients treated with Abiraterone or Enzalutamide. PharmacoEconomics, (Accepted for Publication)

2020

Robles-Zurita, J. A., Briggs, A. , Rana, D. , Quayyum, Z., Oldroyd, K. G., Zeymer, U., Desch, S., de Waha-Thiele, S. and Thiele, H. (2020) Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. European Journal of Health Economics, 21, pp. 1197-1209. (doi: 10.1007/s10198-020-01235-3) (PMID:33029668)

Bouttell, J. et al. (2020) Evidence Review: Assessment of COVID-19 in Primary Care: the Identification of Symptoms, Signs, Characteristics, Comorbidities and Clinical Signs in Adults which may Indicate a Higher Risk of Progression to Severe Disease. Documentation. SIGN, Edinburgh.

Rana, D. et al. (2020) Healthcare Costs for Metastatic Castration Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide in the Pre and Post Chemotherapy Setting. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

This list was generated on Sat Oct 23 01:37:54 2021 BST.
Number of items: 9.

Articles

Rana, D. , Westrop, S., Germeni, E. , Mcgarty, A. , Ells, L., Lally, P., McEwan, M., Melville, C. , Harris, L. and Wu, O. (2021) Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: Protocol for a mixed-methods systematic review. Systematic Reviews, (Accepted for Publication)

Rana, D. et al. (2021) Uterine artery embolization or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial. BJOG: An International Journal of Obstetrics and Gynaecology, (doi: 10.1111/1471-0528.16781) (Early Online Publication)

Stock, S. J. et al. (2021) Cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study: a protocol. BMJ Open, 11(5), e050452. (doi: 10.1136/bmjopen-2021-050452) (PMID:33947741) (PMCID:33947741)

Quinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)

Rana, D. et al. (2021) Healthcare costs for metastatic castration-resistant prostate cancer patients treated with Abiraterone or Enzalutamide. PharmacoEconomics, (Accepted for Publication)

Robles-Zurita, J. A., Briggs, A. , Rana, D. , Quayyum, Z., Oldroyd, K. G., Zeymer, U., Desch, S., de Waha-Thiele, S. and Thiele, H. (2020) Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. European Journal of Health Economics, 21, pp. 1197-1209. (doi: 10.1007/s10198-020-01235-3) (PMID:33029668)

Research Reports or Papers

Bouttell, J. et al. (2021) Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Bouttell, J. et al. (2020) Evidence Review: Assessment of COVID-19 in Primary Care: the Identification of Symptoms, Signs, Characteristics, Comorbidities and Clinical Signs in Adults which may Indicate a Higher Risk of Progression to Severe Disease. Documentation. SIGN, Edinburgh.

Conference or Workshop Item

Rana, D. et al. (2020) Healthcare Costs for Metastatic Castration Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide in the Pre and Post Chemotherapy Setting. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

This list was generated on Sat Oct 23 01:37:54 2021 BST.

Teaching

Dikshyanta is involved in a range of teaching activities within HEHTA, including supervision of MSc Health Technology Assessment (MSc HTA) and Master of Public Health (MPH) students. She contributes to the development and teaching of the HTA: Policy & Principles module on our MSc HTA programme and our Future Learn micro-credentials course Introduction to Health Economics & Health Technology Assessment. She moderates the discussion forum on our Future Learn MOOC. 

Dikshyanta tutors on our annual continuous professional development (CPD) courses Decision Analytic Modelling for Economic Evaluation and Evidence Synthesis for Health Technology Assessment. 

Dikshyanta also develops and delivers courses for external programmes such as the Better Health Programme (BHP) in the Philippines funded by the U.K. Foreign Commonwealth and Development Office Prosperity Fund in partnership with PricewaterhouseCoopers (PwC) and FHI 360.